Publication date: December 2026 Source: JACC: Advances, Volume 5, Issue 12, Part 2 Author(s): Daniel J. Friedman, Iyanuoluwa Ayodele, DaJuanicia Holmes, Brooke Alhanti, Kenneth A. Ellenbogen, Gregg C. Fonarow, Anthony P. Kent, Kevin P. Jackson, Jose A. Joglar, William R. Lewis, Andrea M. Russo, Sreek Vemulapali, Jonathan P. Piccini
Outcomes Among Patients Receiving Watchman LAAO vs Antiplatelet Therapy: A Report From the GWTG-AFIB Registry. // JACC: Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2772963X2600880X?dgcid=rss_sd_all
Outcomes Among Patients Receiving Watchman LAAO vs Antiplatelet Therapy: A Report From the GWTG-AFIB Registry. JACC: Advances. https://www.sciencedirect.com/science/article/pii/S2772963X2600880X?dgcid=rss_sd_all
“Outcomes Among Patients Receiving Watchman LAAO vs Antiplatelet Therapy: A Report From the GWTG-AFIB Registry.” JACC: Advances.
@article{article116943,
title = {Outcomes Among Patients Receiving Watchman LAAO vs Antiplatelet Therapy: A Report From the GWTG-AFIB Registry},
journal = {JACC: Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2772963X2600880X?dgcid=rss_sd_all}
}